These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 18499568
1. Sublingual immunotherapy. Frew AJ. N Engl J Med; 2008 May 22; 358(21):2259-64. PubMed ID: 18499568 [No Abstract] [Full Text] [Related]
2. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy. Wilkinson J. Immunotherapy; 2012 Nov 22; 4(11):1091-2. PubMed ID: 23194357 [No Abstract] [Full Text] [Related]
3. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment. Durham SR. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Nov 22; 96():121-7; discussion 127-31. PubMed ID: 20799452 [No Abstract] [Full Text] [Related]
4. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis]. Wolthers OD, Høst A, Frederiksen B, Halken S. Ugeskr Laeger; 2012 Aug 27; 174(35):1989-92. PubMed ID: 22929576 [Abstract] [Full Text] [Related]
5. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M. J Allergy Clin Immunol; 2007 Dec 27; 120(6):1338-45. PubMed ID: 17935764 [Abstract] [Full Text] [Related]
9. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen. Rondón C, Blanca-López N, Aranda A, Herrera R, Rodriguez-Bada JL, Canto G, Mayorga C, Torres MJ, Campo P, Blanca M. J Allergy Clin Immunol; 2011 Apr 27; 127(4):1069-71. PubMed ID: 21277626 [No Abstract] [Full Text] [Related]
10. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens]. Ohashi Y. Arerugi; 2008 May 27; 57(5):519-23. PubMed ID: 18520172 [No Abstract] [Full Text] [Related]
11. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Agostinis F, Forti S, Di Berardino F. Allergy; 2010 Mar 27; 65(3):410-1. PubMed ID: 19804450 [No Abstract] [Full Text] [Related]
12. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O. Pediatr Allergy Immunol; 2006 Sep 27; 17(6):396-407. PubMed ID: 16925684 [Abstract] [Full Text] [Related]
13. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. TePas EC, Hoyte EG, McIntire JJ, Umetsu DT. Ann Allergy Asthma Immunol; 2004 Jan 27; 92(1):25-31. PubMed ID: 14756461 [Abstract] [Full Text] [Related]
15. Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy? Nakonechna A, Hills J, Moor J, Dore P, Abuzakouk M. Ann Allergy Asthma Immunol; 2015 Jan 27; 114(1):73-4. PubMed ID: 25457868 [No Abstract] [Full Text] [Related]
16. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. Worm M. Eur Ann Allergy Clin Immunol; 2006 Dec 27; 38(10):355-60. PubMed ID: 17274520 [Abstract] [Full Text] [Related]